Foundayo® vs Ozempic®
Two daily GLP-1 medications — one is a brand-new pill, one is a decade-old injection. Here’s how the outcomes and cost compare.
BestGLP1 is not affiliated with, endorsed by, or sponsored by Novo Nordisk A/S, Eli Lilly and Company, or any other manufacturer named on this page. All trademarks are the property of their respective owners.
12.4%
Avg weight loss Foundayo*
From
$149/mo
Foundayo
June 2026
4.9%
Avg weight loss Ozempic*
From
$199/mo
Ozempic
June 2026
What are they?
Ozempic is a once-weekly injectable semaglutide. Foundayo is a daily oral orforglipron pill that can be taken any time without food or water restrictions.
Ozempic is FDA-approved for type 2 diabetes, not for weight loss. Wegovy is the FDA-approved semaglutide formulation for chronic weight management.
Foundayo
Weight ManagementFDA-approved oral GLP-1 receptor agonist for chronic weight management — the first weight-loss pill that can be taken at any time of day with no food or water restrictions. Made by Eli Lilly, approved April 2026.
Maker
Eli Lilly
Approved
2026
Format
Daily oral pill
Max dose
17.2 mg
Ozempic
Type 2 DiabetesFDA-approved to improve blood sugar in adults with Type 2 Diabetes. Some patients using semaglutide as part of a comprehensive medical program may also experience reduced hunger and meaningful weight reduction over time.
Maker
Novo Nordisk
Approved
2017
Format
Weekly injection
Max dose
2.0 mg
Quick comparison
How they stack up on the metrics that matter most.
| Feature | Foundayo | Ozempic |
|---|---|---|
| Active ingredient | Orforglipron | Semaglutide |
| FDA approved for | Weight Management | Type 2 diabetes |
| Avg weight loss | 12.4%† | 4.9%† |
| Administration | Daily oral pill | Weekly injection |
| Insurance | Limited | Broader |
| Monthly Price | From $149/mo | From $199/mo |
Foundayo
Orforglipron
Ozempic
Semaglutide
Foundayo
Weight Management
Ozempic
Type 2 diabetes
Foundayo
12.4%†
Ozempic
4.9%†
Foundayo
Daily oral pill
Ozempic
Weekly injection
Foundayo
Limited
Ozempic
Broader
Foundayo
From $149/mo
Ozempic
From $199/mo
† Average weight loss data: Foundayo — ATTAIN-1 (oral orforglipron 36 mg, 72 weeks); Ozempic — SUSTAIN-1 (semaglutide 1.0 mg, 30 weeks).
More energy,
less weight
How you ramp up
Both medications use a gradual dose escalation to minimize side effects.
Foundayo
- 1
0.8 mg
Month 1
(Daily)
- 2
2.5 mg
Month 2
(Daily)
- 3
5.5 mg
Month 3
(Daily)
- 4
9 mg
Month 4
(Daily)
- 5
14.5 mg
Month 5
(Daily)
- 6
17.2 mg
Month 6+
(Maintenance)
Ozempic
- 1
0.25 mg
Weeks 1–4
- 2
0.5 mg
Weeks 5–8
- 3
1.0 mg
Weeks 9+
(Maintenance)
- 4
2.0 mg
Optional max dose
Start your weight‑loss
journey today
Weight loss compared
Clinical trial data showing average body weight reduction over 68 weeks.
Foundayo (17.2 mg)
Ozempic (1 mg)
† Average weight loss data: Foundayo — ATTAIN-1 (oral orforglipron 36 mg, 72 weeks); Ozempic — SUSTAIN-1 (semaglutide 1.0 mg, 30 weeks).
What to expect
How they stack up on the metrics that matter most.
| Side Effect | Foundayo (36 mg) | Ozempic (1 mg) |
|---|---|---|
| Nausea | ~33.7% | 20.3% |
| Diarrhea | ~23.1% | 8.8% |
| Vomiting | ~24.0% | 9.2% |
| Constipation | ~25.4% | 3.1% |
| Headache | ~9% | N/A |
| Fatigue | ~9% | N/A |
Foundayo (36 mg)
~33.7%
Ozempic (1 mg)
20.3%
Foundayo (36 mg)
~23.1%
Ozempic (1 mg)
8.8%
Foundayo (36 mg)
~24.0%
Ozempic (1 mg)
9.2%
Foundayo (36 mg)
~25.4%
Ozempic (1 mg)
3.1%
Foundayo (36 mg)
~9%
Ozempic (1 mg)
N/A
Foundayo (36 mg)
~9%
Ozempic (1 mg)
N/A
Side effects may be more noticeable during dose escalation, but individual experiences vary and some risks can be serious. GLP-1 medications are not appropriate for everyone. Review important warnings, contraindications, and the FDA label or Medication Guide with a licensed healthcare provider before starting or switching treatment.
The bottom line
Branded GLP-1 medications can offer effective weight loss, requiring individualized risk-benefit clinical evaluation.
Two different GLP-1 options
- Foundayo is an oral GLP-1 medication FDA-approved for chronic weight management in eligible adults. It is taken once daily and may be suitable for patients who prefer an oral option to injectables.
- Ozempic is FDA-approved for type 2 diabetes, with blood-sugar control, weekly dosing convenience, and cardiovascular benefits supported by large clinical trials and long-term safety data.
Providers may pay BestGLP1 a referral fee. We disclose this for FTC compliance; rankings remain editorial.
What you
need to know
In trials, Foundayo (orforglipron) produced about 11.1% average weight loss compared with Ozempic’s 15% over 68 weeks. Ozempic still leads on raw outcomes, but Foundayo is competitive for an oral option and avoids injections entirely.
Foundayo is FDA-approved for chronic weight management, not type 2 diabetes. If diabetes is your primary concern, Ozempic or another GLP-1 with a diabetes indication is usually the better fit — talk to your provider about which approval matches your diagnosis.
Oral orforglipron is taken every day with no food or water restrictions, while Ozempic is a once-weekly self-injection. Pills are typically easier for needle-averse patients, but weekly dosing means fewer total decisions and Ozempic still shows higher average weight loss in trials.
Yes. Both Foundayo and Ozempic require a prescription from a licensed healthcare provider. A consultation is required to assess whether treatment is appropriate for you.
- Foundayo (orforglipron, 36 mg capsule / 17.2 mg tablet equivalent). Trial: ATTAIN-1 (3,127 participants, 72 weeks, adults with obesity or overweight without diabetes). Average weight loss: ~12.4% vs 0.9% placebo.
- Ozempic (semaglutide 1.0 mg). Trial: SUSTAIN 1 (388 participants, 30 weeks, adults with type 2 diabetes inadequately controlled on diet and exercise). Average weight loss: −4.9% vs −1.0% placebo. Sorli et al., Lancet Diabetes Endocrinol 2017.
BestGLP1 publishes these guides for informational and comparison purposes only. The information on this site is not medical advice, diagnosis, or treatment, and is not a substitute for guidance from a licensed healthcare professional. GLP-1 medications must be prescribed and monitored by a qualified provider; consult your provider to determine whether treatment is appropriate for your individual circumstances. Prices, side-effect rates, and clinical figures shown here are general references drawn from manufacturer labelling and published trials, and may not reflect your specific situation.
Find the right
GLP-1 for you
Compare side by side. No signup required.
What's your
target weight?
Let's find your perfect program
Providers may pay BestGLP1 a referral fee. We disclose this for FTC compliance; rankings remain editorial.